New Leaf Venture Partners

company

About

New Leaf Venture Partners is a venture capital firm focused on investments in healthcare technology companies.

  • 11 - 50

Details

Industries
Finance,Financial Services,Venture Capital
Founded date
Jan 1, 2005
Number Of Employee
11 - 50
Operating Status
Active
Investor Type
Venture Capital

New Leaf Venture Partners is a venture capital firm that invests primarily in healthcare technology. The company typically focuses on later stage biopharmaceutical products, early stage medical devices, and laboratory infrastructure technologies.

The New Leaf Ventures (NLV) team has been built over a decade, originating within Sprout Group, the venture capital affiliate of Credit Suisse First Boston. Sprout Group was formed in 1969 and has historically been one of the leading venture capital firms in the country. The team started to invest in healthcare technology in 1993 and since then, has become a leading venture investor in that sector. In 2005, the entire healthcare technology team of Sprout spun out into NLV.

Investments

Number of Investments
Number of Lead Investments
10
1
New Leaf Venture Partners has made 10 investments. Their most recent investment was on Feb 16, 2022, when Star Therapeutics raised $100M.
Date Company Name
Round Money Raised Industry Lead Investor
Feb 16, 2022 Star Therapeutics
Series Unknown $100M
Jun 21, 2021 Cleerly
Series B $43M Apps
Oct 8, 2020 TigerConnect
Series D $11.50M Collaboration
Sep 4, 2019 Passage Bio
Series B $110M Biotechnology
Feb 15, 2019 Passage Bio
Series A $115.50M Biotechnology